Market Tracker

05/26 5:16pm ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

3.54
Delayed Data
As of 4:00pm ET
 -0.11 / -3.01%
Today’s Change
2.28
Today|||52-Week Range
11.65
-23.71%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close3.65
Today’s open3.61
Day’s range3.43 - 3.70
Volume450,832
Average volume (3 months)566,269
Market cap$146.6M
Dividend yield--
Data as of 4:00pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-26.05%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
CYNACynapsus Therapeutic...+0.71+5.83%
TTNPTitan Pharmaceutical...+0.09+1.29%
--Innovative Pharmaceu...-0.01-4.63%
ADHDAlcobra Ltd-0.17-3.28%
Data as of 4:00pm ET, 05/26/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts